Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aripiprazole in Adolescents With Schizophrenia

NCT00102063 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Development & Commercialization, Inc. as lead sponsor.

NCT NCT00102063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aripiprazole in Adolescents With Schizophrenia
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2004
Completion date
August 31, 2006
Enrollment
302 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia